Nachman Norwood & Parrott’s Bristol-Myers Squibb BMY Stock Holding History

Nachman Norwood & Parrott’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$3.4M	Buy	50,961 +42	+0.1%	+$2.74K	0.35%	61
2021 Q1	$3.21M	Buy	50,919 +62	+0.1%	+$3.86K	0.35%	58
2020 Q4	$3.15M	Buy	50,857 +1,059	+2%	+$65.1K	0.37%	54
2020 Q3	$3M	Buy	49,798 +347	+0.7%	+$20.9K	0.4%	49
2020 Q2	$2.91M	Buy	49,451 +186	+0.4%	+$11.1K	0.48%	40
2020 Q1	$2.75M	Sell	49,265 -20	-0%	-$1.22K	0.55%	37
2019 Q4	$3.16M	Sell	49,285 -1,284	-3%	-$73.5K	0.52%	37
2019 Q3	$2.56M	Buy	50,569 +181	+0.4%	+$8.51K	0.46%	47
2019 Q2	$2.29M	Buy	50,388 +1,687	+3%	+$78.6K	0.41%	55
2019 Q1	$2.32M	Sell	48,701 -272	-0.6%	-$13.5K	0.43%	55
2018 Q4	$2.55M	Buy	+48,973	New	+$2.63M	0.53%	38

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Nachman Norwood & Parrott's BMY Position: Q2 2021 in Review

Nachman Norwood & Parrott increased its Bristol-Myers Squibb (BMY) stake by 0.08% in Q2 2021, buying an estimated $2.74K and bringing the position to 50,961 shares worth $3.4M. The position accounts for 0.35% of the portfolio, ranked #61.

Nachman Norwood & Parrott first reported a position in BMY in Q4 2018 and has held it in 11 quarters since. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

Nachman Norwood & Parrott held 50,961 shares of Bristol-Myers Squibb worth $3.4M as of Q2 2021.
Nachman Norwood & Parrott bought 42 Bristol-Myers Squibb shares in Q2 2021, an estimated $2.74K.
Bristol-Myers Squibb made up 0.35% of Nachman Norwood & Parrott's portfolio in Q2 2021, its #61 holding.
Nachman Norwood & Parrott first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 11 quarters since.
2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Nachman Norwood & Parrott's 13F filing for Q2 2021, filed 13 Aug 2021.